A developer of nanoparticle technology for biotech applications.
Nanoplex Technologies is developing nanoparticle-based products for life science research, for ultra-sensitive molecular identification and quantitation, and for authentication and tracking applications. The company's goal is to rapidly convert state-of-the-art nanoscience into practical and valuable products.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 6, 2005 | Series B | $2.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Versant Ventures | — | Series B |